Pay in 4 interest-free payments of $6.47 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Rationale and design of Short-Term EXenatide therapy in Acute ischaemic Stroke (STEXAS): a randomised, open-label, parallel-group study
Avoid Desensitization Use lower to moderate doses (4080 mcg/day) to minimize the risk of diminishing returns
Strinic et al., 2017), bupivacaine (Zivanovic-Posilovic et al., 2016), lidocaine (Vukojevic et al., 2018
Transient ischemic attack (TIA, including limb-shaking TIA )
According to FDA labeling, these medications are indicated for improving glycemic control in adults with type 2 diabetes and, in higher doses for certain formulations, for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity
US$ 28.41
US$ 22.53
US$ 28.90
US$ 24.61
